Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, et al. Idarucizumab for dabigatran reversal. N Engl J Med 2015 Aug;373(6):511-20.
RAVE Investigators. Randomized controlled trial of intravenous antivenom versus placebo for latrodectism: the second Redback Antivenom Evaluation (RAVE-II) study. Ann Emerg Med 2014 Dec;64(6):620-8.
Levine M, Boyer EW, Pozner CN, Geib AJ, Thomsen T, Mick N, Thomas SH. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med 2007 Sep;35(9):2071-5.
Houston M, Hendrickson RG. Decontamination. Crit Care Clin 2005 Oct;21(4):653-72.
Cao D, Heard K, Foran M, Koyfman A. Intravenous lipid emulsion in the emergency department: a systematic review of recent literature. J Emerg Med 2015 Mar;48(3):387-97.
Pal R, Balt S, Erowid E, Erowid F, Baggott MJ, Mendelson J, Galloway GP. Ketamine is associated with lower urinary tract signs and symptoms. Drug Alcohol Depend 2013 Sep;132(1-2):189-94.
Centers for Disease Control and Prevention (CDC). Illnesses and deaths among persons attending an electronic dance-music festival – New York City, 2013. MMWR Morb Mortal Wkly Rep 2014 Dec;63(50):1195-8.
Kim HK, Nelson LS. Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opin Drug Saf 2015 Jul;14(7):1137-46.
Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med 2014 Feb;370(7):640-9.
Marraffa JM, Holland MG, Sullivan RW, Morgan BW, Oakes JA, Wiegand TJ, Hodgman MJ. Cardiac conduction disturbance after loperamide abuse. Clin Toxicol (Phila) 2014 Nov;52(9):952-7.
Nelson LS, Loh M, Perrone J. Assuring safety of inherently unsafe medications: the FDA risk evaluation and mitigation strategies. J Med Toxicol 2014 Jun;10(2):165-72.
Grundlingh J, Dargan PI, El-Zanfaly M, Wood DM. 2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death. J Med Toxicol 2011 Sep;7(3):205-12.